1 Terbinafine Hydrochloride Drug Market Overview 1.1 Product Overview and Scope of Terbinafine Hydrochloride Drug 1.2 Terbinafine Hydrochloride Drug Segment by Type 1.2.1 Global Terbinafine Hydrochloride Drug Sales Growth Rate Comparison by Type (2021-2027) 1.2.2 Topical 1.2.3 Oral 1.3 Terbinafine Hydrochloride Drug Segment by Application 1.3.1 Global Terbinafine Hydrochloride Drug Sales Comparison by Application: (2021-2027) 1.3.2 Fingernail Infection 1.3.3 Toenail Infection 1.3.4 Others 1.4 Global Terbinafine Hydrochloride Drug Market Size Estimates and Forecasts 1.4.1 Global Terbinafine Hydrochloride Drug Revenue 2016-2027 1.4.2 Global Terbinafine Hydrochloride Drug Sales 2016-2027 1.4.3 Terbinafine Hydrochloride Drug Market Size by Region: 2016 Versus 2021 Versus 2027 2 Terbinafine Hydrochloride Drug Market Competition by Manufacturers 2.1 Global Terbinafine Hydrochloride Drug Sales Market Share by Manufacturers (2016-2021) 2.2 Global Terbinafine Hydrochloride Drug Revenue Market Share by Manufacturers (2016-2021) 2.3 Global Terbinafine Hydrochloride Drug Average Price by Manufacturers (2016-2021) 2.4 Manufacturers Terbinafine Hydrochloride Drug Manufacturing Sites, Area Served, Product Type 2.5 Terbinafine Hydrochloride Drug Market Competitive Situation and Trends 2.5.1 Terbinafine Hydrochloride Drug Market Concentration Rate 2.5.2 The Global Top 5 and Top 10 Largest Terbinafine Hydrochloride Drug Players Market Share by Revenue 2.5.3 Global Terbinafine Hydrochloride Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans 3 Terbinafine Hydrochloride Drug Retrospective Market Scenario by Region 3.1 Global Terbinafine Hydrochloride Drug Retrospective Market Scenario in Sales by Region: 2016-2021 3.2 Global Terbinafine Hydrochloride Drug Retrospective Market Scenario in Revenue by Region: 2016-2021 3.3 North America Terbinafine Hydrochloride Drug Market Facts & Figures by Country 3.3.1 North America Terbinafine Hydrochloride Drug Sales by Country 3.3.2 North America Terbinafine Hydrochloride Drug Revenue by Country 3.3.3 U.S. 3.3.4 Canada 3.4 Europe Terbinafine Hydrochloride Drug Market Facts & Figures by Country 3.4.1 Europe Terbinafine Hydrochloride Drug Sales by Country 3.4.2 Europe Terbinafine Hydrochloride Drug Revenue by Country 3.4.3 Germany 3.4.4 France 3.4.5 U.K. 3.4.6 Italy 3.4.7 Russia 3.5 Asia Pacific Terbinafine Hydrochloride Drug Market Facts & Figures by Region 3.5.1 Asia Pacific Terbinafine Hydrochloride Drug Sales by Region 3.5.2 Asia Pacific Terbinafine Hydrochloride Drug Revenue by Region 3.5.3 China 3.5.4 Japan 3.5.5 South Korea 3.5.6 India 3.5.7 Australia 3.5.8 Taiwan 3.5.9 Indonesia 3.5.10 Thailand 3.5.11 Malaysia 3.5.12 Philippines 3.5.13 Vietnam 3.6 Latin America Terbinafine Hydrochloride Drug Market Facts & Figures by Country 3.6.1 Latin America Terbinafine Hydrochloride Drug Sales by Country 3.6.2 Latin America Terbinafine Hydrochloride Drug Revenue by Country 3.6.3 Mexico 3.6.4 Brazil 3.6.5 Argentina 3.7 Middle East and Africa Terbinafine Hydrochloride Drug Market Facts & Figures by Country 3.7.1 Middle East and Africa Terbinafine Hydrochloride Drug Sales by Country 3.7.2 Middle East and Africa Terbinafine Hydrochloride Drug Revenue by Country 3.7.3 Turkey 3.7.4 Saudi Arabia 3.7.5 U.A.E 4 Global Terbinafine Hydrochloride Drug Historic Market Analysis by Type 4.1 Global Terbinafine Hydrochloride Drug Sales Market Share by Type (2016-2021) 4.2 Global Terbinafine Hydrochloride Drug Revenue Market Share by Type (2016-2021) 4.3 Global Terbinafine Hydrochloride Drug Price by Type (2016-2021) 5 Global Terbinafine Hydrochloride Drug Historic Market Analysis by Application 5.1 Global Terbinafine Hydrochloride Drug Sales Market Share by Application (2016-2021) 5.2 Global Terbinafine Hydrochloride Drug Revenue Market Share by Application (2016-2021) 5.3 Global Terbinafine Hydrochloride Drug Price by Application (2016-2021) 6 Key Companies Profiled 6.1 Novartis 6.1.1 Novartis Corporation Information 6.1.2 Novartis Description and Business Overview 6.1.3 Novartis Terbinafine Hydrochloride Drug Sales, Revenue and Gross Margin (2016-2021) 6.1.4 Novartis Terbinafine Hydrochloride Drug Product Portfolio 6.1.5 Novartis Recent Developments/Updates 6.2 GSK 6.2.1 GSK Corporation Information 6.2.2 GSK Description and Business Overview 6.2.3 GSK Terbinafine Hydrochloride Drug Sales, Revenue and Gross Margin (2016-2021) 6.2.4 GSK Terbinafine Hydrochloride Drug Product Portfolio 6.2.5 GSK Recent Developments/Updates 6.3 TEVA 6.3.1 TEVA Corporation Information 6.3.2 TEVA Description and Business Overview 6.3.3 TEVA Terbinafine Hydrochloride Drug Sales, Revenue and Gross Margin (2016-2021) 6.3.4 TEVA Terbinafine Hydrochloride Drug Product Portfolio 6.3.5 TEVA Recent Developments/Updates 6.4 Dr. Reddy's Laboratories 6.4.1 Dr. Reddy's Laboratories Corporation Information 6.4.2 Dr. Reddy's Laboratories Description and Business Overview 6.4.3 Dr. Reddy's Laboratories Terbinafine Hydrochloride Drug Sales, Revenue and Gross Margin (2016-2021) 6.4.4 Dr. Reddy's Laboratories Terbinafine Hydrochloride Drug Product Portfolio 6.4.5 Dr. Reddy's Laboratories Recent Developments/Updates 6.5 CIPLA LTD 6.5.1 CIPLA LTD Corporation Information 6.5.2 CIPLA LTD Description and Business Overview 6.5.3 CIPLA LTD Terbinafine Hydrochloride Drug Sales, Revenue and Gross Margin (2016-2021) 6.5.4 CIPLA LTD Terbinafine Hydrochloride Drug Product Portfolio 6.5.5 CIPLA LTD Recent Developments/Updates 6.6 TARO 6.6.1 TARO Corporation Information 6.6.2 TARO Description and Business Overview 6.6.3 TARO Terbinafine Hydrochloride Drug Sales, Revenue and Gross Margin (2016-2021) 6.6.4 TARO Terbinafine Hydrochloride Drug Product Portfolio 6.6.5 TARO Recent Developments/Updates 6.7 InvaGen Pharmaceuticals 6.6.1 InvaGen Pharmaceuticals Corporation Information 6.6.2 InvaGen Pharmaceuticals Description and Business Overview 6.6.3 InvaGen Pharmaceuticals Terbinafine Hydrochloride Drug Sales, Revenue and Gross Margin (2016-2021) 6.4.4 InvaGen Pharmaceuticals Terbinafine Hydrochloride Drug Product Portfolio 6.7.5 InvaGen Pharmaceuticals Recent Developments/Updates 6.8 Breckenridge Pharmaceutical 6.8.1 Breckenridge Pharmaceutical Corporation Information 6.8.2 Breckenridge Pharmaceutical Description and Business Overview 6.8.3 Breckenridge Pharmaceutical Terbinafine Hydrochloride Drug Sales, Revenue and Gross Margin (2016-2021) 6.8.4 Breckenridge Pharmaceutical Terbinafine Hydrochloride Drug Product Portfolio 6.8.5 Breckenridge Pharmaceutical Recent Developments/Updates 6.9 Harris Pharmaceutical 6.9.1 Harris Pharmaceutical Corporation Information 6.9.2 Harris Pharmaceutical Description and Business Overview 6.9.3 Harris Pharmaceutical Terbinafine Hydrochloride Drug Sales, Revenue and Gross Margin (2016-2021) 6.9.4 Harris Pharmaceutical Terbinafine Hydrochloride Drug Product Portfolio 6.9.5 Harris Pharmaceutical Recent Developments/Updates 6.10 Glenmark 6.10.1 Glenmark Corporation Information 6.10.2 Glenmark Description and Business Overview 6.10.3 Glenmark Terbinafine Hydrochloride Drug Sales, Revenue and Gross Margin (2016-2021) 6.10.4 Glenmark Terbinafine Hydrochloride Drug Product Portfolio 6.10.5 Glenmark Recent Developments/Updates 6.11 Orchid Healthcare 6.11.1 Orchid Healthcare Corporation Information 6.11.2 Orchid Healthcare Terbinafine Hydrochloride Drug Description and Business Overview 6.11.3 Orchid Healthcare Terbinafine Hydrochloride Drug Sales, Revenue and Gross Margin (2016-2021) 6.11.4 Orchid Healthcare Terbinafine Hydrochloride Drug Product Portfolio 6.11.5 Orchid Healthcare Recent Developments/Updates 6.12 APOTEX 6.12.1 APOTEX Corporation Information 6.12.2 APOTEX Terbinafine Hydrochloride Drug Description and Business Overview 6.12.3 APOTEX Terbinafine Hydrochloride Drug Sales, Revenue and Gross Margin (2016-2021) 6.12.4 APOTEX Terbinafine Hydrochloride Drug Product Portfolio 6.12.5 APOTEX Recent Developments/Updates 6.13 Jilin Wantong Group 6.13.1 Jilin Wantong Group Corporation Information 6.13.2 Jilin Wantong Group Terbinafine Hydrochloride Drug Description and Business Overview 6.13.3 Jilin Wantong Group Terbinafine Hydrochloride Drug Sales, Revenue and Gross Margin (2016-2021) 6.13.4 Jilin Wantong Group Terbinafine Hydrochloride Drug Product Portfolio 6.13.5 Jilin Wantong Group Recent Developments/Updates 6.14 Cussess 6.14.1 Cussess Corporation Information 6.14.2 Cussess Terbinafine Hydrochloride Drug Description and Business Overview 6.14.3 Cussess Terbinafine Hydrochloride Drug Sales, Revenue and Gross Margin (2016-2021) 6.14.4 Cussess Terbinafine Hydrochloride Drug Product Portfolio 6.14.5 Cussess Recent Developments/Updates 6.15 Hubei Hengan Fulin Pharm 6.15.1 Hubei Hengan Fulin Pharm Corporation Information 6.15.2 Hubei Hengan Fulin Pharm Terbinafine Hydrochloride Drug Description and Business Overview 6.15.3 Hubei Hengan Fulin Pharm Terbinafine Hydrochloride Drug Sales, Revenue and Gross Margin (2016-2021) 6.15.4 Hubei Hengan Fulin Pharm Terbinafine Hydrochloride Drug Product Portfolio 6.15.5 Hubei Hengan Fulin Pharm Recent Developments/Updates 6.16 Xiuzheng Pharmaceutical 6.16.1 Xiuzheng Pharmaceutical Corporation Information 6.16.2 Xiuzheng Pharmaceutical Terbinafine Hydrochloride Drug Description and Business Overview 6.16.3 Xiuzheng Pharmaceutical Terbinafine Hydrochloride Drug Sales, Revenue and Gross Margin (2016-2021) 6.16.4 Xiuzheng Pharmaceutical Terbinafine Hydrochloride Drug Product Portfolio 6.16.5 Xiuzheng Pharmaceutical Recent Developments/Updates 7 Terbinafine Hydrochloride Drug Manufacturing Cost Analysis 7.1 Terbinafine Hydrochloride Drug Key Raw Materials Analysis 7.1.1 Key Raw Materials 7.1.2 Key Suppliers of Raw Materials 7.2 Proportion of Manufacturing Cost Structure 7.3 Manufacturing Process Analysis of Terbinafine Hydrochloride Drug 7.4 Terbinafine Hydrochloride Drug Industrial Chain Analysis 8 Marketing Channel, Distributors and Customers 8.1 Marketing Channel 8.2 Terbinafine Hydrochloride Drug Distributors List 8.3 Terbinafine Hydrochloride Drug Customers 9 Terbinafine Hydrochloride Drug Market Dynamics 9.1 Terbinafine Hydrochloride Drug Industry Trends 9.2 Terbinafine Hydrochloride Drug Growth Drivers 9.3 Terbinafine Hydrochloride Drug Market Challenges 9.4 Terbinafine Hydrochloride Drug Market Restraints 10 Global Market Forecast 10.1 Terbinafine Hydrochloride Drug Market Estimates and Projections by Type 10.1.1 Global Forecasted Sales of Terbinafine Hydrochloride Drug by Type (2022-2027) 10.1.2 Global Forecasted Revenue of Terbinafine Hydrochloride Drug by Type (2022-2027) 10.2 Terbinafine Hydrochloride Drug Market Estimates and Projections by Application 10.2.1 Global Forecasted Sales of Terbinafine Hydrochloride Drug by Application (2022-2027) 10.2.2 Global Forecasted Revenue of Terbinafine Hydrochloride Drug by Application (2022-2027) 10.3 Terbinafine Hydrochloride Drug Market Estimates and Projections by Region 10.3.1 Global Forecasted Sales of Terbinafine Hydrochloride Drug by Region (2022-2027) 10.3.2 Global Forecasted Revenue of Terbinafine Hydrochloride Drug by Region (2022-2027) 11 Research Finding and Conclusion 12 Methodology and Data Source 12.1 Methodology/Research Approach 12.1.1 Research Programs/Design 12.1.2 Market Size Estimation 12.1.3 Market Breakdown and Data Triangulation 12.2 Data Source 12.2.1 Secondary Sources 12.2.2 Primary Sources 12.3 Author List 12.4 Disclaimer

List of Tables Table 1. Global Terbinafine Hydrochloride Drug Sales (K Units) Growth Rate Comparison by Type (2021-2027) Table 2. Global Terbinafine Hydrochloride Drug Sales (K Units) Comparison by Application (2021-2027) Table 3. Global Terbinafine Hydrochloride Drug Market Size by Region (US$ Million) (2016 VS 2021 VS 2027) Table 4. Key Manufacturers Terbinafine Hydrochloride Drug Covered in This Study Table 5. Global Terbinafine Hydrochloride Drug Sales (K Units) of Key Manufacturers (2016-2021) Table 6. Global Terbinafine Hydrochloride Drug Sales Market Share by Manufacturers (2016-2021) Table 7. Global Terbinafine Hydrochloride Drug Revenue (US$ Million) by Manufacturers (2016-2021) Table 8. Global Terbinafine Hydrochloride Drug Revenue Share by Manufacturers (2016-2021) Table 9. Global Market Terbinafine Hydrochloride Drug Average Price (USD/Unit) of Key Manufacturers (2016-2021) Table 10. Manufacturers Terbinafine Hydrochloride Drug Manufacturing Sites and Area Served Table 11. Manufacturers Terbinafine Hydrochloride Drug Product Type Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 13. Global Terbinafine Hydrochloride Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Terbinafine Hydrochloride Drug as of 2020) Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans Table 15. Global Terbinafine Hydrochloride Drug Sales by Region (2016-2021) & (K Units) Table 16. Global Terbinafine Hydrochloride Drug Sales Market Share by Region (2016-2021) Table 17. Global Terbinafine Hydrochloride Drug Revenue by Region (2016-2021) & (US$ Million) Table 18. North America Terbinafine Hydrochloride Drug Sales by Country (2016-2021) & (K Units) Table 19. North America Terbinafine Hydrochloride Drug Sales Market Share by Country (2016-2021) Table 20. North America Terbinafine Hydrochloride Drug Revenue by Country (2016-2021) & (US$ Million) Table 21. North America Terbinafine Hydrochloride Drug Revenue Market Share by Country (2016-2021) Table 22. Europe Terbinafine Hydrochloride Drug Sales by Country (2016-2021) & (K Units) Table 23. Europe Terbinafine Hydrochloride Drug Sales Market Share by Country (2016-2021) Table 24. Europe Terbinafine Hydrochloride Drug Revenue by Country (2016-2021) & (US$ Million) Table 25. Europe Terbinafine Hydrochloride Drug Revenue Market Share by Country (2016-2021) Table 26. Asia Pacific Terbinafine Hydrochloride Drug Sales by Region (2016-2021) & (K Units) Table 27. Asia Pacific Terbinafine Hydrochloride Drug Sales Market Share by Region (2016-2021) Table 28. Asia Pacific Terbinafine Hydrochloride Drug Revenue by Region (2016-2021) & (US$ Million) Table 29. Asia Pacific Terbinafine Hydrochloride Drug Revenue Market Share by Region (2016-2021) Table 30. Latin America Terbinafine Hydrochloride Drug Sales by Country (2016-2021) & (K Units) Table 31. Latin America Terbinafine Hydrochloride Drug Sales Market Share by Country (2016-2021) Table 32. Latin America Terbinafine Hydrochloride Drug Revenue by Country (2016-2021) & (US$ Million) Table 33. Latin America Terbinafine Hydrochloride Drug Revenue Market Share by Country (2016-2021) Table 34. Middle East and Africa Terbinafine Hydrochloride Drug Sales by Country (2016-2021) & (K Units) Table 35. Middle East and Africa Terbinafine Hydrochloride Drug Sales Market Share by Country (2016-2021) Table 36. Middle East and Africa Terbinafine Hydrochloride Drug Revenue by Country (2016-2021) & (US$ Million) Table 37. Middle East and Africa Terbinafine Hydrochloride Drug Revenue Market Share by Country (2016-2021) Table 38. Global Terbinafine Hydrochloride Drug Sales (K Units) by Type (2016-2021) Table 39. Global Terbinafine Hydrochloride Drug Sales Market Share by Type (2016-2021) Table 40. Global Terbinafine Hydrochloride Drug Revenue (Million US$) by Type (2016-2021) Table 41. Global Terbinafine Hydrochloride Drug Revenue Share by Type (2016-2021) Table 42. Global Terbinafine Hydrochloride Drug Price (USD/Unit) by Type (2016-2021) Table 43. Global Terbinafine Hydrochloride Drug Sales (K Units) by Application (2016-2021) Table 44. Global Terbinafine Hydrochloride Drug Sales Market Share by Application (2016-2021) Table 45. Global Terbinafine Hydrochloride Drug Revenue (Million US$) by Application (2016-2021) Table 46. Global Terbinafine Hydrochloride Drug Revenue Share by Application (2016-2021) Table 47. Global Terbinafine Hydrochloride Drug Price (USD/Unit) by Application (2016-2021) Table 48. Novartis Corporation Information Table 49. Novartis Description and Business Overview Table 50. Novartis Terbinafine Hydrochloride Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 51. Novartis Terbinafine Hydrochloride Drug Product Table 52. Novartis Recent Developments/Updates Table 53. GSK Corporation Information Table 54. GSK Description and Business Overview Table 55. GSK Terbinafine Hydrochloride Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 56. GSK Terbinafine Hydrochloride Drug Product Table 57. GSK Recent Developments/Updates Table 58. TEVA Corporation Information Table 59. TEVA Description and Business Overview Table 60. TEVA Terbinafine Hydrochloride Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 61. TEVA Terbinafine Hydrochloride Drug Product Table 62. TEVA Recent Developments/Updates Table 63. Dr. Reddy's Laboratories Corporation Information Table 64. Dr. Reddy's Laboratories Description and Business Overview Table 65. Dr. Reddy's Laboratories Terbinafine Hydrochloride Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 66. Dr. Reddy's Laboratories Terbinafine Hydrochloride Drug Product Table 67. Dr. Reddy's Laboratories Recent Developments/Updates Table 68. CIPLA LTD Corporation Information Table 69. CIPLA LTD Description and Business Overview Table 70. CIPLA LTD Terbinafine Hydrochloride Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 71. CIPLA LTD Terbinafine Hydrochloride Drug Product Table 72. CIPLA LTD Recent Developments/Updates Table 73. TARO Corporation Information Table 74. TARO Description and Business Overview Table 75. TARO Terbinafine Hydrochloride Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 76. TARO Terbinafine Hydrochloride Drug Product Table 77. TARO Recent Developments/Updates Table 78. InvaGen Pharmaceuticals Corporation Information Table 79. InvaGen Pharmaceuticals Description and Business Overview Table 80. InvaGen Pharmaceuticals Terbinafine Hydrochloride Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 81. InvaGen Pharmaceuticals Terbinafine Hydrochloride Drug Product Table 82. InvaGen Pharmaceuticals Recent Developments/Updates Table 83. Breckenridge Pharmaceutical Corporation Information Table 84. Breckenridge Pharmaceutical Description and Business Overview Table 85. Breckenridge Pharmaceutical Terbinafine Hydrochloride Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 86. Breckenridge Pharmaceutical Terbinafine Hydrochloride Drug Product Table 87. Breckenridge Pharmaceutical Recent Developments/Updates Table 88. Harris Pharmaceutical Corporation Information Table 89. Harris Pharmaceutical Description and Business Overview Table 90. Harris Pharmaceutical Terbinafine Hydrochloride Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 91. Harris Pharmaceutical Terbinafine Hydrochloride Drug Product Table 92. Harris Pharmaceutical Recent Developments/Updates Table 93. Glenmark Corporation Information Table 94. Glenmark Description and Business Overview Table 95. Glenmark Terbinafine Hydrochloride Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 96. Glenmark Terbinafine Hydrochloride Drug Product Table 97. Glenmark Recent Developments/Updates Table 98. Orchid Healthcare Corporation Information Table 99. Orchid Healthcare Description and Business Overview Table 100. Orchid Healthcare Terbinafine Hydrochloride Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 101. Orchid Healthcare Terbinafine Hydrochloride Drug Product Table 102. Orchid Healthcare Recent Developments/Updates Table 103. APOTEX Corporation Information Table 104. APOTEX Description and Business Overview Table 105. APOTEX Terbinafine Hydrochloride Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 106. APOTEX Terbinafine Hydrochloride Drug Product Table 107. APOTEX Recent Developments/Updates Table 108. Jilin Wantong Group Corporation Information Table 109. Jilin Wantong Group Description and Business Overview Table 110. Jilin Wantong Group Terbinafine Hydrochloride Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 111. Jilin Wantong Group Terbinafine Hydrochloride Drug Product Table 112. Jilin Wantong Group Recent Developments/Updates Table 113. Cussess Corporation Information Table 114. Cussess Description and Business Overview Table 115. Cussess Terbinafine Hydrochloride Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 116. Cussess Terbinafine Hydrochloride Drug Product Table 117. Cussess Recent Developments/Updates Table 118. Hubei Hengan Fulin Pharm Corporation Information Table 119. Hubei Hengan Fulin Pharm Description and Business Overview Table 120. Hubei Hengan Fulin Pharm Terbinafine Hydrochloride Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 121. Hubei Hengan Fulin Pharm Terbinafine Hydrochloride Drug Product Table 122. Hubei Hengan Fulin Pharm Recent Developments/Updates Table 123. Xiuzheng Pharmaceutical Corporation Information Table 124. Xiuzheng Pharmaceutical Description and Business Overview Table 125. Xiuzheng Pharmaceutical Terbinafine Hydrochloride Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 126. Xiuzheng Pharmaceutical Terbinafine Hydrochloride Drug Product Table 127. Xiuzheng Pharmaceutical Recent Developments/Updates Table 128. Production Base and Market Concentration Rate of Raw Material Table 129. Key Suppliers of Raw Materials Table 130. Terbinafine Hydrochloride Drug Distributors List Table 131. Terbinafine Hydrochloride Drug Customers List Table 132. Terbinafine Hydrochloride Drug Market Trends Table 133. Terbinafine Hydrochloride Drug Growth Drivers Table 134. Terbinafine Hydrochloride Drug Market Challenges Table 135. Terbinafine Hydrochloride Drug Market Restraints Table 136. Global Terbinafine Hydrochloride Drug Sales Forecast by Type (2022-2027) & (K Units) Table 137. Global Terbinafine Hydrochloride Drug Sales Market Share Forecast by Type (2022-2027) Table 138. Global Terbinafine Hydrochloride Drug Revenue Forecast by Type (2022-2027) & (US$ Million) Table 139. Global Terbinafine Hydrochloride Drug Revenue Market Share Forecast by Type (2022-2027) Table 140. Global Terbinafine Hydrochloride Drug Sales Forecast by Application (2022-2027) & (K Units) Table 141. Global Terbinafine Hydrochloride Drug Sales Market Share Forecast by Application (2022-2027) Table 142. Global Terbinafine Hydrochloride Drug Revenue Forecast by Application (2022-2027) & (US$ Million) Table 143. Global Terbinafine Hydrochloride Drug Revenue Market Share Forecast by Application (2022-2027) Table 144. Global Terbinafine Hydrochloride Drug Sales Forecast by Region (2022-2027) & (K Units) Table 145. Global Terbinafine Hydrochloride Drug Sales Market Share Forecast by Region (2022-2027) Table 146. Global Terbinafine Hydrochloride Drug Revenue Forecast by Region (2022-2027) & (US$ Million) Table 147. Global Terbinafine Hydrochloride Drug Revenue Market Share Forecast by Region (2022-2027) Table 148. Research Programs/Design for This Report Table 149. Key Data Information from Secondary Sources Table 150. Key Data Information from Primary Sources List of Figures Figure 1. Product Picture of Terbinafine Hydrochloride Drug Figure 2. Global Terbinafine Hydrochloride Drug Market Share by Type in 2020 & 2027 Figure 3. Topical Product Picture Figure 4. Oral Product Picture Figure 5. Global Terbinafine Hydrochloride Drug Market Share by Application in 2020 & 2027 Figure 6. Fingernail Infection Figure 7. Toenail Infection Figure 8. Others Figure 9. Global Terbinafine Hydrochloride Drug Revenue, (US$ Million), 2016 VS 2021 VS 2027 Figure 10. Global Terbinafine Hydrochloride Drug Market Size 2016-2027 (US$ Million) Figure 11. Global Terbinafine Hydrochloride Drug Sales 2016-2027 (K Units) Figure 12. Global Terbinafine Hydrochloride Drug Market Size Market Share by Region: 2016 VS 20210 VS 2027 Figure 13. Terbinafine Hydrochloride Drug Sales Share by Manufacturers in 2020 Figure 14. Global Terbinafine Hydrochloride Drug Revenue Share by Manufacturers in 2020 Figure 15. The Global 5 and 10 Largest Terbinafine Hydrochloride Drug Players: Market Share by Revenue in 2020 Figure 16. Terbinafine Hydrochloride Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021 Figure 17. Global Terbinafine Hydrochloride Drug Sales Market Share by Region (2016-2021) Figure 18. Global Terbinafine Hydrochloride Drug Sales Market Share by Region in 2020 Figure 19. Global Terbinafine Hydrochloride Drug Revenue Market Share by Region (2016-2021) Figure 20. Global Terbinafine Hydrochloride Drug Revenue Market Share by Region in 2020 Figure 21. U.S. Terbinafine Hydrochloride Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 22. Canada Terbinafine Hydrochloride Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 23. Germany Terbinafine Hydrochloride Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 24. France Terbinafine Hydrochloride Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 25. U.K. Terbinafine Hydrochloride Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 26. Italy Terbinafine Hydrochloride Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 27. Russia Terbinafine Hydrochloride Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 28. China Terbinafine Hydrochloride Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 29. Japan Terbinafine Hydrochloride Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 30. South Korea Terbinafine Hydrochloride Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 31. India Terbinafine Hydrochloride Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 32. Australia Terbinafine Hydrochloride Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 33. Taiwan Terbinafine Hydrochloride Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 34. Indonesia Terbinafine Hydrochloride Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 35. Thailand Terbinafine Hydrochloride Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 36. Malaysia Terbinafine Hydrochloride Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 37. Philippines Terbinafine Hydrochloride Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 38. Vietnam Terbinafine Hydrochloride Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 39. Mexico Terbinafine Hydrochloride Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 40. Brazil Terbinafine Hydrochloride Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 41. Argentina Terbinafine Hydrochloride Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 42. Turkey Terbinafine Hydrochloride Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 43. Saudi Arabia Terbinafine Hydrochloride Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 44. U.A.E Terbinafine Hydrochloride Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 45. Sales Market Share of Terbinafine Hydrochloride Drug by Type (2016-2021) Figure 46. Sales Market Share of Terbinafine Hydrochloride Drug by Application (2016-2021) Figure 47. Sales Market Share of Terbinafine Hydrochloride Drug by Application in 2020 Figure 48. Revenue Share of Terbinafine Hydrochloride Drug by Application (2016-2021) Figure 49. Revenue Share of Terbinafine Hydrochloride Drug by Application in 2020 Figure 50. Manufacturing Cost Structure of Terbinafine Hydrochloride Drug Figure 51. Manufacturing Process Analysis of Terbinafine Hydrochloride Drug Figure 52. Terbinafine Hydrochloride Drug Industrial Chain Analysis Figure 53. Channels of Distribution Figure 54. Distributors Profiles Figure 55. Bottom-up and Top-down Approaches for This Report Figure 56. Data Triangulation Figure 57. Key Executives Interviewed

Novartis GSK TEVA Dr. Reddy's Laboratories CIPLA LTD TARO InvaGen Pharmaceuticals Breckenridge Pharmaceutical Harris Pharmaceutical Glenmark Orchid Healthcare APOTEX Jilin Wantong Group Cussess Hubei Hengan Fulin Pharm Xiuzheng Pharmaceutical